🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

23+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 20 of 23 recruiting trials for “Osteosarcoma

Phase 2RecruitingNCT07477457

A Study of Gefitinib, Trametinib, Disulfiram, and Sunitinib in Addition to Standard Chemotherapy in People With Osteosarcoma

👨‍⚕️ Damon Reed, MD, Memorial Sloan Kettering Cancer Center📍 7 sites📅 Started Mar 2026View details ↗
Phase 1RecruitingNCT06492954

Atezolizumab in Combination With Stereotactic Body Radiation Therapy (SBRT) and Surgery for Relapsed Osteosarcoma

👨‍⚕️ Thomas Cash, MD, MSc, Emory University📍 1 site📅 Started Mar 2026View details ↗
NARecruitingNCT07129226

Musculoskeletal Cancers Remote Monitoring and Care

🏥 Case Comprehensive Cancer Center📍 1 site📅 Started Feb 2026View details ↗
Phase 1RecruitingNCT07144254

Tegavivint With Gemcitabine in Patients With Relapsed or Refractory Osteosarcoma

👨‍⚕️ Thomas Cash, MD, MSc, Emory University📍 1 site📅 Started Jan 2026View details ↗
Phase 1RecruitingNCT07227571

Genetically Engineered Cells (FH-FOLR1 ST CAR T Cells) for the Treatment of Advanced Refractory or Recurrent/Progressive Osteosarcoma, FIERCe Trial

👨‍⚕️ Michelle Choe, MD, Fred Hutch/University of Washington/Seattle Children's Cancer Consortium📍 1 site📅 Started Jan 2026View details ↗
Phase 1, PHASE2RecruitingNCT06892678

DFMO Maintenance for Patients With Relapsed/Refractory Ewing Sarcoma or Osteosarcoma

👨‍⚕️ Alice Lee, MD, Montefiore Medical Center📍 1 site📅 Started Apr 2025View details ↗
Phase 2RecruitingNCT06650514

A Phase 2 Pilot Study to Evaluate the Safety and the Anti-Tumour Activity of the Myc Inhibitor OMO-103 Administered Intravenously in Patients With Advanced High-Grade Osteosarcoma

🏥 Vall d'Hebron Institute of Oncology📍 1 site📅 Started Dec 2024View details ↗
Phase 2RecruitingNCT06714383

Trilaciclib Combing Chemotherapy in the Neoadjuvant Treatment of Osteosarcoma

🏥 Peking University People's Hospital📍 1 site📅 Started Nov 2024View details ↗
Phase 1RecruitingNCT06235125

Safety and Feasibility of Intraoperative Visualization With Cytalux in Children

👨‍⚕️ Timothy Lautz, MD, Ann & Robert H Lurie Children's Hospital of Chicago📍 1 site📅 Started Apr 2024View details ↗
RecruitingNCT06384404

Upfront Surgical Resection for Osteosarcoma

👨‍⚕️ Alice Lee, M.D., Montefiore Medical Center📍 1 site📅 Started Mar 2024View details ↗
RecruitingNCT06064682

An Organoid-based Functional Precision Medicine Trial in Osteosarcoma

👨‍⚕️ Alice Soragni, PhD, University of California at Los Angeles📍 1 site📅 Started Feb 2024View details ↗
RecruitingNCT06324916

Donor Site Morbidity After Free Vascularized Fibular Graft

🏥 Assiut University📍 1 site📅 Started Jan 2024View details ↗
Phase 2RecruitingNCT05926492

A Clinical Study of Surufatinib Combined With Chemotherapy as Neoadjuvant Treatment in Osteosarcoma

🏥 Second Affiliated Hospital, School of Medicine, Zhejiang University📍 1 site📅 Started Jan 2024View details ↗
Phase 1, PHASE2RecruitingNCT06778603

B7-H3 NIR Imaging for Osteosarcoma Surgery

🏥 Peking University People's Hospital📍 1 site📅 Started Jan 2024View details ↗
RecruitingNCT05942456

Soluble B7-H3 as a Biomarker for Osteosarcoma

🏥 Peking University People's Hospital📍 1 site📅 Started Jun 2023View details ↗
Phase 2RecruitingNCT06114225

Pulmonary Resectable Osteosarcoma Treated by Metastasectomy and Pre-operative Immunotherapy and Stereotactic Body Radiotherapy (PROMIS): a Prospective Clinical Trial

👨‍⚕️ Weibin Zhang, PhD, MD, Ruijin Hospital📍 1 site📅 Started Jun 2023View details ↗
Phase 1, PHASE2RecruitingNCT05588648

Study to Assess Safety and Efficacy of Vactosertib in Adolescents and Adults With Recurrent, Refractory or Progressive Osteosarcoma

🏥 MedPacto, Inc.📍 3 sites📅 Started May 2023View details ↗
Phase 3RecruitingNCT05328258

Use of GnRHa During Chemotherapy for Fertility Protection

🏥 Kenny Rodriguez-Wallberg📍 17 sites📅 Started Mar 2023View details ↗
Phase 2RecruitingNCT05182164

Combination of Pembrolizumab and Cabozantinib in Patients With Advanced Sarcomas

🏥 Institut Bergonié📍 10 sites📅 Started Apr 2022View details ↗
Phase 2RecruitingNCT04758000

Metformin as Maintenance Therapy in Patients With Bone Sarcoma and High Risk of Relapse

👨‍⚕️ Alessandra Longhi, MD, Istituto Ortopedico Rizzoli IRCSS, Bologna, Italy📍 1 site📅 Started Mar 2021View details ↗
Page 1 of 2Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →